Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

Lignende værker

• Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population
  af: MORGAN, Jake R., et al.
  Udgivet: (2017)
• Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting
  af: Morgan, Jake R., et al.
  Udgivet: (2020)
• Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse
  af: Murphy, Sean M., et al.
  Udgivet: (2018)
• Opioid prescribing history prior to heroin overdose among commercially insured adults
  af: Lagisetty, Pooja, et al.
  Udgivet: (2020)
• Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose
  af: Follman, Sarah, et al.
  Udgivet: (2019)